Shannon Thyme Klinger - Feb 27, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ James Dillon, as Attorny-in-Fact
Stock symbol
MRNA
Transactions as of
Feb 27, 2025
Transactions value $
-$93,319
Form type
4
Date filed
2/28/2025, 04:25 PM
Previous filing
Feb 14, 2025
Next filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +3.09K +14.21% 24.9K Feb 27, 2025 Direct F1, F2
transaction MRNA Common Stock Tax liability -$50.2K -1.5K -6.02% $33.58 23.4K Feb 27, 2025 Direct F3
transaction MRNA Common Stock Options Exercise +2.65K +11.35% 26K Feb 27, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$43.1K -1.28K -4.93% $33.58 24.7K Feb 27, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -3.09K -25% $0.00 9.28K Feb 27, 2025 Common Stock 3.09K Direct F1, F4
transaction MRNA Restricted Stock Units Options Exercise $0 -2.65K -100% $0.00 0 Feb 27, 2025 Common Stock 2.65K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Includes 342 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on December 13, 2024.
F3 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.